Dysmenorrhea: effectiveness and acceptability of treatment with a drug containing 2 mg of chloromadinone acetate and 0.03 mg of ethinyl estradiol
According to various researchers, primary dysmenorrhea affects between 20% and 91% of women. Combined oral contraceptives (COCs) are the first choice drugs in young women with primary dysmenorrhea. They have high efficiency, therapeutic and protective effects. In order to assess the acceptability of...
Main Authors: | V N Prilepskaia, A N Mgerian, E A Mezhevitinova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2017-06-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28661/pdf |
Similar Items
-
COMPARATIVE ANALYSIS OF REQUIREMENTS FOR QUALITY CONTROL OF ETHINYL ESTRADIOL AND LEVONORGESTREL CONTAINING MEDICINAL PRODUCTS
by: V. I. Seredenko, et al.
Published: (2018-03-01) -
Dose and delivery method impact cognitive outcome of Ethinyl Estradiol administration in the surgically menopausal rat
Published: (2012) -
Simultaneous total occlusion of two coronary arteries associated with use of drospirenone-ethinyl estradiol (oral contraceptive)
by: Hüsnü Atmaca, et al.
Published: (2018-01-01) -
Comparison of Metformin and Ethinyl Estradiol-Cyproterone Acetate in the Management of Polycystic Ovary Syndrome
by: Sadaf Ajaib, et al.
Published: (2018-09-01) -
Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study
by: Li Li, et al.
Published: (2020-02-01)